Posts

Essays, analysis, and insights on private equity, tokenization, and decentralized finance.

Who Pays for the Science?

The AI build is usually discussed as a technology story. But underneath it sits a capital-allocation question that may matter just as much: who is actually structured to hold the risks being created? This first piece in a 3-part series starts at the bottom of the stack with basic scientific research. It is long-duration, failure-prone, and difficult for the company funding it to fully monetize. Historically, that has made it an awkward fit for private balance sheets. Yet frontier AI companies are spending heavily on exactly this kind of work. The article examines why basic research behaves like the first-loss equity tranche of technological development, why neither governments nor private companies are obvious natural holders of that risk, and what the current AI investment cycle may be telling us about a decades-old economic assumption.

Priced in a Room

Kalshi has built an exchange around putting prices on unresolved questions. One of the biggest unresolved questions now concerns Kalshi itself. New York is challenging whether its core sports business is a federally regulated derivatives market or unlicensed gambling. Less than 2 weeks later, reports emerged that Kalshi was in talks to raise at a $40 billion valuation. The lawsuit's headline damages figure and the reported valuation aren't directly comparable. But together they expose something more interesting: a binary regulatory outcome could materially reshape Kalshi's economics, yet there is no public market continuously pricing that risk. For a company built around markets for uncertain outcomes, perhaps its most consequential contract is the one you can't trade.

Who Counts the Capex

SpaceX reported $18.37 billion in quarterly capex. Two days later, it announced the first phase of a semiconductor campus that could eventually involve far more spending. The difference between those numbers is more important than the market reaction. Committed spending gets measured. Announced spending keeps its optionality. That matters as AI infrastructure spending accelerates toward extraordinary levels and a growing share is financed with debt. It matters even more as frontier AI companies prepare to enter public markets. The deeper question is whether quarterly reporting is built to price research programs whose costs arrive now but whose payoff may be decades away. SpaceX offers a useful case study in what happens when long-duration technological bets meet the short-duration accountability of public markets.

Count Holders, Not Dollars

Tokenization headlines tend to focus on dollar value. But if the real question is whether access is expanding, there may be a better number to watch: holders. Wallets holding tokenized stocks passed 1.02 million in early August, up 33% in just 8 days and from fewer than 59,000 a year ago. Tokenized equities now represent roughly 63% of all RWA holders on-chain, far ahead of any other category. The dollars tell us how large tokenization is becoming. The holder count tells us something more interesting: how many people are actually participating.

Eligible Was Not Sold

SpaceX’s first major post-IPO lock-up release offered a useful test of how these events actually behave. Ahead of the 6 August release, 3 claims were on the table: the conditional 455.8 million-share tranche would remain locked, eligibility to sell would not necessarily mean actual selling, and an expanding free float could create additional passive demand alongside new supply. The conditional tranche did fail its price test, leaving 911.5 million shares eligible for release. SpaceX’s free float then jumped from roughly 4.9% to 11.8%. But instead of collapsing under the new supply, the stock rose 6.1% on release day and closed at $133.11 the following session, up another 15.83%. Two of the 3 predictions held. The third was never actually tested. The bigger lesson is that a lock-up expiry is more complicated than “more shares = more selling.” Eligibility, actual selling, float mechanics, and market demand are separate forces, and the SpaceX release showed why that distinction matters.

Kalshi Wants to Be Worth $40 Billion. Watch the Venue, Not the Round.

Kalshi's reported $40 billion valuation isn't just pricing today's business. It's pricing an outcome. The company has grown at an extraordinary pace, with valuation climbing from roughly $2 billion in mid-2025 to a reported $40 billion today, alongside explosive trading volume and revenue growth. But the more interesting question is what investors believe Kalshi is becoming. Is it simply a fast-growing prediction market, or is the market beginning to value it as a new piece of financial infrastructure? The article explores why that distinction matters, how regulation sits at the center of the investment case, and what a $40 billion valuation is really saying about the future of prediction markets.

The Round Trip: What SpaceX’s Falling Stock Is Actually Asking

Since its June 12 IPO, SpaceX has completed a full round trip, pricing at $135, surging above $225 within days, and now trading below its offer price. The debate is no longer about what SpaceX was worth as a private company. The market is trying to determine what kind of public company it is becoming. One increasingly useful way to think about SpaceX is as an emerging hyperscaler. It may not follow the path of Amazon, Microsoft, or Google, but its combination of launch infrastructure, Starlink, and AI compute is creating a business model that looks increasingly familiar, while pointing toward a very different destination.

The Market Priced In SpaceX’s Index Add. It Cannot Price In What Comes Next.

Earlier this week, the argument was that SpaceX's Nasdaq-100 inclusion failed to lift the stock because the market had already priced it in. The rule change was public, the timing was known, and the passive buying was predictable. The obvious follow-up question is whether the same logic applies to upcoming lock-up expirations. If everyone knows the dates and the number of shares involved, shouldn't those already be priced in too? The answer highlights an important distinction in market structure: must versus may. Index funds must buy. Insiders may sell. That difference explains why some highly anticipated events disappear into the price, while others continue to move markets.

The Index Had to Buy SpaceX. The Stock Fell. This Is Why.

SpaceX entered the Nasdaq-100 just 15 trading days after its IPO, triggering an estimated $4 billion in forced buying from index funds. The stock still fell about 7% and closed below its debut price. That was not a market failure. It was a reminder that widely anticipated demand is often priced in before the actual buying begins. When every participant can see the same trade coming, the event itself may become the exit rather than the catalyst. The real lesson is not that index inclusion failed. It is that mechanical demand does not guarantee upside when the market has already traded ahead of it.

Going Public by Degrees

Tokenized IPOs moved from theory to reality in 2026. Securitize’s NYSE listing showed how an issuer-sponsored token can represent the same underlying share on-chain, while new models from Backpack, Superstate, and Ondo are beginning to move IPO allocation and debut-day access onto Solana. With tokenized equity volume reaching roughly $3.86 billion in June, the infrastructure is taking shape. The next question is whether tokenization changes only how shares settle, or who gets access in the first place.